Skip to main content
OpenTrials

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

6,011 public trials 1,221 recruiting studies
Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Completed

Dose-Dense Temozolomide + Lapatinib for Recurrent Ependymoma

NCT00826241

Conditions
Brain Diseases, Brain Neoplasms, Brain Tumors, +17 more
Locations
  • University of California, San Francisco San Francisco, California, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • University of Pittsburgh Medical Center - Hillman Cancer Center Pittsburgh, Pennsylvania, United States
View Trial Details
Completed

Feasibility Trial of the Modified Atkins Diet and Bevacizumab for Recurrent Glioblastoma

NCT02768389

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +15 more
Locations
  • University of Cincinnati Cincinnati, Ohio, United States
  • University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
  • Cleveland Clinic Taussig Cancer Institute, Case Comprehensive cancer Center Cleveland, Ohio, United States
  • OhioHealth Research and Innovation Institute Columbus, Ohio, United States
View Trial Details
Completed

Tetra-O-Methyl Nordihydroguaiaretic Acid in Treating Patients With Recurrent High-Grade Glioma

NCT00404248

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +17 more
Locations
  • UAB Comprehensive Cancer Center Birmingham, Alabama, United States
  • H. Lee Moffitt Cancer Center and Research Institute at University of South Florida Tampa, Florida, United States
  • Winship Cancer Institute of Emory University Atlanta, Georgia, United States
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
View Trial Details
Completed

Phase 1 Study of Intradermal LV305 in Patients With Locally Advanced, Relapsed or Metastatic Cancer Expressing NY-ESO-1

NCT02122861

Conditions
Melanoma, Melanoma - Currently Enrolling, Neoplasms, +12 more
Locations
  • San Francisco Oncology Associates San Francisco, California, United States
  • Yale University New Haven, Connecticut, United States
  • Dana Farber Harvard Cancer Center Boston, Massachusetts, United States
  • Mayo Clinic Rochester, Minnesota, United States
View Trial Details

Related conditions